Teladoc Health Inc [TDOC] stock is trading at $7.81, up 1.83%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The TDOC shares have gain 6.40% over the last week, with a monthly amount drifted -4.76%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Teladoc Health Inc [NYSE: TDOC] stock has seen the most recent analyst activity on July 25, 2025, when Mizuho initiated its Neutral rating and assigned the stock a price target of $10. Previously, Goldman started tracking the stock with Buy rating on November 15, 2024, and set its price target to $14. On September 17, 2024, Jefferies reiterated its Hold rating and revised its price target to $10 on the stock. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $22 on February 29, 2024. Leerink Partners initiated its recommendation with a Market Perform and recommended $17 as its price target on February 26, 2024. DA Davidson downgraded its rating to Neutral for this stock on January 17, 2024, and downed its price target to $22. In a note dated January 03, 2024, Barclays initiated an Overweight rating and provided a target price of $26 on this stock.
Teladoc Health Inc [TDOC] stock has fluctuated between $6.35 and $15.21 over the past year. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Teladoc Health Inc [NYSE: TDOC] shares were valued at $7.81 at the most recent close of the market. An investor can expect a potential return of 28.04% based on the average TDOC price forecast.
Analyzing the TDOC fundamentals
Teladoc Health Inc [NYSE:TDOC] reported sales of 2.54B for the trailing twelve months, which represents a drop of -1.64%. Gross Profit Margin for this corporation currently stands at 0.7% with Operating Profit Margin at -0.11%, Pretax Profit Margin comes in at -0.09%, and Net Profit Margin reading is -0.08%. To continue investigating profitability, this company’s Return on Assets is posted at -0.07, Equity is -0.14 and Total Capital is -0.11. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.72.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.70 points at the first support level, and at 7.58 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.90, and for the 2nd resistance point, it is at 7.99.
Ratios To Look Out For
For context, Teladoc Health Inc’s Current Ratio is 2.59. Also, the Quick Ratio is 2.49, while the Cash Ratio stands at 1.69. Considering the valuation of this stock, the price to sales ratio is 0.54, the price to book ratio is 0.97.
Transactions by insiders
Recent insider trading involved Rodrigues Fernando M., President of BetterHelp, that happened on Jun 03 ’25 when 4174.0 shares were sold. President of BetterHelp, Rodrigues Fernando M. completed a deal on Jun 02 ’25 to sell 2358.0 shares. Meanwhile, CHIEF LEGAL OFFICER, SECRETARY Vandervoort Adam C sold 5808.0 shares on Jun 02 ’25.
